-
INO Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Inovio Pharmaceuticals (INO)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 21.69 mm | 21.69 mm | 21.69 mm | 21.69 mm | 21.69 mm | 21.69 mm |
Cash burn (monthly) | 4.23 mm | (no burn) | 9.12 mm | 9.95 mm | 9.15 mm | 9.22 mm |
Cash used (since last report) | 18.46 mm | n/a | 39.73 mm | 43.38 mm | 39.87 mm | 40.21 mm |
Cash remaining | 3.23 mm | n/a | -18.05 mm | -21.69 mm | -18.19 mm | -18.52 mm |
Runway (months of cash) | 0.8 | n/a | -2.0 | -2.2 | -2.0 | -2.0 |
13F holders | Current |
---|---|
Total holders | 100 |
Opened positions | 20 |
Closed positions | 19 |
Increased positions | 26 |
Reduced positions | 20 |
13F shares | Current |
---|---|
Total value | 49.00 bn |
Total shares | 8.57 mm |
Total puts | 157.07 k |
Total calls | 237.38 k |
Total put/call ratio | 0.7 |
Largest owners | Shares | Value |
---|---|---|
BlackRock | 1.89 mm | $10.90 bn |
Deep Track Capital | 1.80 mm | $10.43 bn |
Vanguard | 1.80 mm | $10.39 bn |
Geode Capital Management | 621.63 k | $3.59 bn |
STT State Street | 490.66 k | $2.84 bn |
Renaissance Technologies | 331.07 k | $1.91 bn |
NTRS Northern Trust | 205.79 k | $1.19 bn |
Dimensional Fund Advisors | 130.51 k | $754.47 mm |
GMT Capital | 126.12 k | $728.98 mm |
MS Morgan Stanley | 95.13 k | $549.86 mm |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
18 Dec 24 | Michael John Sumner | RSU Common Stock | Grant | Acquire A | No | No | 0 | 4,292 | 0.00 | 4,292 |
18 Dec 24 | Michael John Sumner | Common Stock Option Common Stock | Grant | Acquire A | No | No | 1.78 | 5,708 | 10.16 k | 5,708 |
30 Jun 24 | Michael John Sumner | Common Stock | Option exercise | Acquire M | No | No | 0 | 2,917 | 0.00 | 8,219 |
30 Jun 24 | Michael John Sumner | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 2,917 | 0.00 | 2,916 |
21 May 24 | Yarno Wendy L | RSU Common Stock | Grant | Acquire A | No | No | 0 | 2,167 | 0.00 | 2,167 |
21 May 24 | Yarno Wendy L | Common Stock Options Common Stock | Grant | Acquire A | No | No | 10.99 | 2,917 | 32.06 k | 2,917 |
21 May 24 | Dansey Roger D | RSU Common Stock | Grant | Acquire A | No | No | 0 | 2,167 | 0.00 | 2,167 |
21 May 24 | Dansey Roger D | Common Stock Options Common Stock | Grant | Acquire A | No | No | 10.99 | 2,917 | 32.06 k | 2,917 |
21 May 24 | David B. Weiner | RSU Common Stock | Grant | Acquire A | No | No | 0 | 2,167 | 0.00 | 2,167 |
21 May 24 | David B. Weiner | Common Stock Options Common Stock | Grant | Acquire A | No | No | 10.99 | 2,917 | 32.06 k | 2,917 |